183 related articles for article (PubMed ID: 29288113)
1. Early Botulinum Toxin Injections in Infants With Musculoskeletal Disorders: A Systematic Review of Safety and Effectiveness.
Bourseul JS; Molina A; Lintanf M; Houx L; Chaléat-Valayer E; Pons C; Brochard S
Arch Phys Med Rehabil; 2018 Jun; 99(6):1160-1176.e5. PubMed ID: 29288113
[TBL] [Abstract][Full Text] [Related]
2. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
[TBL] [Abstract][Full Text] [Related]
3. The Effectiveness and Safety of Botulinum Toxin Injections for the Treatment of Congenital Muscular Torticollis.
Qiu X; Cui Z; Tang G; Deng H; Xiong Z; Han S; Tang S
J Craniofac Surg; 2020; 31(8):2160-2166. PubMed ID: 33136847
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin treatment in children].
Sätilä H; Vähäsarja V; Paavilainen P
Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
[TBL] [Abstract][Full Text] [Related]
7. Safety of botulinum toxin type A: a systematic review and meta-analysis.
Naumann M; Jankovic J
Curr Med Res Opin; 2004 Jul; 20(7):981-90. PubMed ID: 15265242
[TBL] [Abstract][Full Text] [Related]
8. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL
Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
[TBL] [Abstract][Full Text] [Related]
12. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections.
Lannin N; Scheinberg A; Clark K
Dev Med Child Neurol; 2006 Jun; 48(6):533-9. PubMed ID: 16700950
[TBL] [Abstract][Full Text] [Related]
13. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
14. Indications and effects of botulinum toxin A for obstetric brachial plexus injury: a systematic literature review.
Gobets D; Beckerman H; de Groot V; Van Doorn-Loogman MH; Becher JG
Dev Med Child Neurol; 2010 Jun; 52(6):517-28. PubMed ID: 20163432
[TBL] [Abstract][Full Text] [Related]
15. Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
Albavera-Hernández C; Rodríguez JM; Idrovo AJ
Clin Rehabil; 2009 May; 23(5):394-407. PubMed ID: 19389744
[TBL] [Abstract][Full Text] [Related]
16. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
Boyd RN; Hays RM
Eur J Neurol; 2001 Nov; 8 Suppl 5():1-20. PubMed ID: 11851730
[TBL] [Abstract][Full Text] [Related]
17. Sonography-guided injection of botulinum toxin A in children with cerebral palsy.
Berweck S; Feldkamp A; Francke A; Nehles J; Schwerin A; Heinen F
Neuropediatrics; 2002 Aug; 33(4):221-3. PubMed ID: 12368994
[TBL] [Abstract][Full Text] [Related]
18. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
Bradley LJ; Huntley JS
Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322
[No Abstract] [Full Text] [Related]
19. Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?
Wasiak J; Hoare BJ; Hender KM
Med J Aust; 2002 Aug; 177(3):158. PubMed ID: 12149089
[No Abstract] [Full Text] [Related]
20. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
